Form 4: Vanda Pharmaceuticals CFO Kevin Patrick Moran Reports Sale of Shares to Cover Tax Obligations
SEC Form 4 Filing
Kevin Patrick Moran, SVP, CFO & Treasurer of Vanda Pharmaceuticals, reported the sale of 2,251 shares of common stock to cover tax obligations related to RSU settlement.
Summary
- On July 29, 2024, Kevin Patrick Moran, the SVP, CFO & Treasurer of Vanda Pharmaceuticals Inc., reported a transaction involving the company's common stock.
- Moran sold 2,251 shares of common stock at a price of $5.9203 per share.
- This sale was executed to satisfy tax obligations related to the acquisition of shares from the settlement of vested Restricted Stock Units (RSUs).
- The sale was conducted under the 'same day sale' provisions of the RSU agreements.
- Following the transaction, Moran directly owns 228,763 shares of Vanda Pharmaceuticals Inc.
- Moran also indirectly owns 635 shares through his wife.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It doesn't indicate any significant positive or negative sentiment.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares acquired through equity compensation to cover taxes.
Key Dates
| Date | Description |
|---|---|
| 07/29/2024 | Date of stock sale transaction. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.